Open AccessImpact of liver test abnormalities and chronic liver disease on the clinical outcomes of patients hospitalized with COVID-19
Author(s) -
Ankita Kondhalkar,
Rakesh Kumar Jha,
Neha Bhatt,
Roshan Kumar Jha
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns2.5022
Subject(s) - medicine , covid-19 , chronic liver disease , outbreak , observational study , disease , liver disease , pandemic , virus , corona (planetary geology) , gastroenterology , virology , infectious disease (medical specialty) , cirrhosis , physics , astrobiology , venus
The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) or novel corona virus disease (COVID-19) pandemic is sweeping the globe. Latest information on the outbreak of the corona virus epidemic in 2019, which was caused by the extreme acute respiratory syndrome corona virus 2 strains, has begun to shed light on the disease's effects on the liver. However, no studies have systematically to date, there have been no impaired liver tests in COVID-19 patients. In patients with irregular liver test results, we looked at the clinical features of COVID-19. The goal of this research was to explain the clinical outcomes of COVID-19 in patients with irregular liver tests and CLD. AIM: We performed an observational study to see how irregular liver tests and patients' clinical outcomes were influenced by chronic liver disease admitted to SMHRC Nagpur. MATERIAL AND METHODS: The research included 200 people aged 25 to 65 years old who had been diagnosed with corona positive and were admitted to Shalinitai Meghe Hospital in Nagpur. They were split up into different parties. One group had chronic liver disease, and the other did not, but both groups had patients that were corona positive.